Table 4.

Patient characteristics and time from diagnosis to start of treatment (days) in patients receiving radical prostatectomy or radiation therapy

	n	Crude model		Multivariate model*
		Median (IQR)	P-value	Adjusted parameter estimate (95% CI), P-value
Intercept		N/A		49 (41.2-58.9)
Age (y)			< .0001		.030
≤60	397	69 (53)		Ref
>60 to ≤70	351	76 (59)		7 (0.14-12.2)
>70	94	105 (67)		6 (−10.7-20.8)
Race/Ethnicity			< .0001		.048
White	396	63.5 (48)		Ref
Black	286	85 (70)		7 (2.6-12.8)
Hispanic/Latino	101	82 (47)		10 (−0.58 to 28.4)
Other	59	89 (81)		4 (−10.6 to 24.5)
Primary language spoken			.0001		.393
English	679	72 (58)		Ref
Spanish	78	78.5 (57)		−1 (−24.4 to 11.2)
Haitian Creole	39	108 (105)		20 (−10.0 to 54.6)
Other	46	90 (107)		14 (−6.7 to 25.7)
Insurance status			< .0001		<.0001
Commercial/Private	350	64 (47)		Ref
Medicaid/Free care	207	82 (65)		11 (4.5-15.7)
Medicare/Military	285	84 (72)		9 (0.16-13.9)
Marital status			< .0001		.066
Married	522	69 (58)		Ref
Single	211	80 (65)		5 (0.40-11.6)
Other	117	84 (63)		7 (1.3-17.8)
AJCC			.059		.032
Stage II	756	74 (60)		Ref
Stage III	86	82 (59)		9 (1.0-16.4)
Risk category			< .0001		<.0001
Low	396	67 (49)		Ref
Intermediate	359	78 (55)		2 (−3.6 to 5.9)
High	87	120 (86)		25 (8.8-40.5)
Treatment type			< .0001		<.0001
Radical prostatectomy	661	67 (47)		Ref
Radiation therapy	181	116 (93)		34 (25.0-50.0)

AJCC, American Joint Committee on Cancer; CI, confidence interval; IQR, interquartile range; N/A, not available; Ref, reference.

Note: Overall median time to treatment is 75 days (IQR = 60 days).

^*Multivariate model included all characteristics with P < .1 in the crude model.